Overall survival (OS) analysis using the LinkedOmics database revealed that PAAD patients with high COL10A1 expression had shorter overall survival than those with low expression (P = 1.923 × 10− 3, Fig. 2C). This evidence concerns the gene COL10A1 and pancreatic adenocarcinoma.